Vida Ventures Advisors, LLC
- SEC CIK
- 0001831423
- Latest filing
- Nov 3, 2025
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 11, 2021. Long positions only.
- Positions
- 8
- No 13F data for Q4 2020
- Portfolio value
- $395.8M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PRAXPraxis Precision Medicines, Inc. | COM | 2,939,329 | $96.3M | 24.3% | – | – | History |
| KNTEKinnate Biopharma Inc. | COM | 2,747,433 | $85.6M | 21.6% | – | – | History |
| KRONKronos Bio, Inc. | COM | 2,765,314 | $80.9M | 20.4% | – | – | History |
| ALLOAllogene Therapeutics, Inc. | COM | 1,798,163 | $63.5M | 16.0% | – | – | History |
| DYNDyne Therapeutics, Inc. | COM | 2,960,046 | $46.0M | 11.6% | – | – | History |
| OYSTOyster Point Pharma, Inc. | COM | 778,468 | $14.2M | 3.6% | – | – | History |
| QTTBQ32 Bio Inc. | COM | 770,845 | $7.25M | 1.8% | – | – | History |
| ASMBAssembly Biosciences, Inc. | COM | 450,000 | $2.07M | 0.5% | – | – | History |